Price
CHART BY
Frequently asked questions
What is NeuroGenesis's market capitalization?
The market capitalization of NeuroGenesis is $8.23K. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for NeuroGenesis?
NeuroGenesis's Earnings Per Share (EPS) over the trailing twelve months (TTM) is 0.0001. EPS indicates the company's profitability on a per-share basis.
What is NeuroGenesis's revenue over the trailing twelve months?
Over the trailing twelve months, NeuroGenesis reported a revenue of $399.16K.
What is the EBITDA for NeuroGenesis?
NeuroGenesis's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $24.46K. EBITDA measures the company's overall financial performance.
Financials
- Market Cap
- $8.23K
- EPS (TTM)
- 0.0001
- Revenue (TTM)
- $399.16K
- EBITDA (TTM)
- $24.46K
Information
NeuroGenesis, Inc. manufactures and markets nutritional supplements of a particular type. Its products are designed to increase the health of people suffering from a variety of mental and physical health disorders, such as hyperactivity, effects of anxiety and reactions to stressful situations, addictions and other physical disorders. The company was founded on November 13, 1984 and is headquartered in League City, TX.
- Industries
- Other Pharmaceuticals
- Sector
- Health Care
Identifier
- Primary Ticker
- NEUN
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet